(Q37580092)

English

XMT-1001, a novel polymeric camptothecin pro-drug in clinical development for patients with advanced cancer

scientific article published on 12 August 2009

Statements

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit